These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25286051)

  • 1. Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization.
    Kim I; Wu G; Chai NN; Klein AS; Jordan S
    Transplantation; 2014 Dec; 98(12):1262-70. PubMed ID: 25286051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal anti-interleukin-6 receptor antibody attenuates donor-specific antibody responses in a mouse model of allosensitization.
    Wu G; Chai N; Kim I; Klein AS; Jordan SC
    Transpl Immunol; 2013 Mar; 28(2-3):138-43. PubMed ID: 23562586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization.
    Kim I; Wu G; Chai NN; Klein AS; Jordan SC
    Transpl Immunol; 2016 Sep; 38():84-92. PubMed ID: 27507323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis.
    Terabe F; Fujimoto M; Serada S; Shinzaki S; Iijima H; Tsujii M; Hayashi N; Nomura S; Kawahata H; Jang MH; Miyasaka M; Mihara M; Ohsugi Y; Kishimoto T; Naka T
    Inflamm Bowel Dis; 2011 Feb; 17(2):491-502. PubMed ID: 20602470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
    Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF
    Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibrutinib suppresses alloantibody responses in a mouse model of allosensitization.
    Kim I; Wu G; Chai NN; Klein AS; Jordan S
    Transpl Immunol; 2017 Dec; 45():59-64. PubMed ID: 28951258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model.
    Fang X; Cui S; Lee H; Min JW; Lim SW; Oh EJ; Yang CW; Shin YJ; Chung BH
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-21 Receptor Blockade Shifts the Follicular T Cell Balance and Reduces
    Nian Y; Xiong Z; Zhan P; Wang Z; Xu Y; Wei J; Zhao J; Fu Y
    Front Immunol; 2021; 12():661580. PubMed ID: 33897706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells.
    Chen X; Zhang M; Liao M; Graner MW; Wu C; Yang Q; Liu H; Zhou B
    Am J Respir Crit Care Med; 2010 Apr; 181(7):734-42. PubMed ID: 20019339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model.
    Min JW; Shin YJ; Lee H; Kim BM; Park KH; Doh KC; Kim TM; Lim SW; Yang CW; Oh EJ; Chung BH
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.